TITLE

Surgery for T4 non-small cell lung cancer

AUTHOR(S)
Pramesh, C.S.; Mistry, Rajesh C.; Pantvaidya, Gouri H.; Raina, Sudip
PUB. DATE
April 2004
SOURCE
European Journal of Cardio-Thoracic Surgery;Apr2004, Vol. 25 Issue 4, p661
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
12576240

 

Related Articles

  • Postgraduate Study Guide.  // Pulmonary Reviews;Apr2010, Vol. 15 Issue 4, p8 

    A quiz about non-small cell lung cancer is presented.

  • Lung cancer. Holdstock, Ruth // Practice Nurse;11/5/2010, Vol. 40 Issue 8, p17 

    The article offers information on treatment and management of lung cancer and examines how to best support patients who are undergoing treatment for this disease. Lung cancer is considered to be the second most common cancer in Great Britain. The two main types of primary lung cancer include...

  • Lung Cancer.  // Current Medical Literature: Respiratory Medicine;2008, Vol. 22 Issue 2, p44 

    The article presents abstracts on lung cancer which include survival after surgery in stage IA and IB non-small cell lung cancer, the implications of overdiagnosis for lung cancer screening and the association of venous thromboembolism and mortality with recombinant erythropoietin and...

  • Research Progress of Lobe-specific Lymphadenectomy on early stage Lung Cancer Operation. Jian CHEN; Yang SHEN-TU // Chinese Journal of Lung Cancer;Jan2011, Vol. 14 Issue 1, p63 

    Systematic nodes dissection be the standard procedure for lung cancer during operation. While Surgery for early lung cancer lymph node removal method has been controversial, particularly for clinical early stage non-small cell lung cancer that has presenced several methods of lymph node...

  • Surgery.  // Current Medical Literature: Lung Cancer;2012, Vol. 6 Issue 2, p39 

    This section presents clinical reviews related to surgical intervention in treatment of lung cancer. One study suggests surgical resection for stage I and II small cell carcinoma of the lung. Details on a phase 3 study of induction treatment with concurrent chemotherapy versus chemotherapy...

  • Küçük Hücreli Dışı AkciÄŸer Kanserinde Profilaktik Kranial Işınlama. Dırıer, Ahmet; Karadayi, Bilgehan // International Journal of Hematology & Oncology / UHOD: Uluslarar;Mar2008, Vol. 18 Issue 1, p57 

    More than fifty percent local control can be assured with curative radiotherapy, chemoradiotherapy or neoadjuvant chemoradiotherapy preceding surgery in locally advanced non-small cell lung cancer. While an increased overall survival and decreased non-brain distant metastases can be achieved...

  • Surgery.  // Current Medical Literature: Lung Cancer;2011, Vol. 5 Issue 2, p49 

    The article discusses research on surgery to treat lung cancer. It references several studies, including "Percutaneous Radiofrequency Ablation of Clinical Stage 1 Non-Small Cell Lunch Cancer," "Impact of Neoadjuvant Chemoradiotherapy Followed by Surgical Resection on Node-Negative T3 and T4...

  • Does Delaying Adjuvant Chemotherapy for Non-small Cell Lung Cancer Affect Survival? Shapiro, Gary R. // Clinical Oncology Alert;Jun2013, Vol. 29 Issue 6, p42 

    Synopsis: One-third of non-small cell lung cancer patients treated with adjuvant chemotherapy start it more than 10 weeks after surgery. Although the time interval between surgery and initiation of adjuvant chemotherapy impacts survival in colorectal and breast cancers, delaying adjuvant...

  • Manage Patients With Non-Small Cell Lung Cancer. Becze, Elisa // ONS Connect;Oct2008, Vol. 23 Issue 10, p18 

    This article provides updates in the management and treatment of non-small cell lung cancer (NSCLC). It presents a list of common symptoms of lung cancer, including coughing, dyspnea, chest pain, hoarseness, anorexia and weight loss. It also offers drugs for the treatment of NSCLC and their...

  • Genetic alterations predict lung cancer recurrence. Aisner, Joseph // Hem/Onc Today;4/25/2008, Vol. 9 Issue 7, p34 

    The article provides information on a study on early lung cancer recurrence prediction. Findings show that methylation of the promoter region of four genes is linked to early recurrence in patients with non-small cell lung cancer (NSCLC) who are treated with curative surgery. It references a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics